| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |